Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway
出版年份 2018 全文链接
标题
Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway
作者
关键词
-
出版物
Nature Reviews Endocrinology
Volume 14, Issue 10, Pages 605-623
出版商
Springer Nature America, Inc
发表日期
2018-09-04
DOI
10.1038/s41574-018-0087-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Effects of Systemic Therapy of PEGylated NEL-Like Protein 1 (NELL-1) on Fracture Healing in Mice
- (2018) Justine Tanjaya et al. AMERICAN JOURNAL OF PATHOLOGY
- Sclerostin deficiency modifies the development of CKD-MBD in mice
- (2018) Nadine Kaesler et al. BONE
- Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists
- (2018) Gill Holdsworth et al. BONE
- Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
- (2018) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture
- (2018) Chor-Wing Sing et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases
- (2018) Luc Rochette et al. PHARMACOLOGY & THERAPEUTICS
- Sclerostin Blockade and Zoledronic Acid Improve Bone Mass and Strength in Male Mice With Exogenous Hyperthyroidism
- (2017) Elena Tsourdi et al. ENDOCRINOLOGY
- Radial artery sclerostin expression in chronic kidney disease stage 5 predialysis patients: a cross-sectional observational study
- (2017) Hua Zhou et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Osteoporosis and ischemic cardiovascular disease
- (2017) Michel Laroche et al. JOINT BONE SPINE
- Abdominal aortic calcification and the risk of bone fractures: a meta-analysis of prospective cohort studies
- (2017) Dailin Wei et al. JOURNAL OF BONE AND MINERAL METABOLISM
- New Insights Into the Local and Systemic Functions of Sclerostin: Regulation of Quiescent Bone Lining Cells and Beige Adipogenesis in Peripheral Fat Depots
- (2017) Jesus Delgado-Calle et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relationship Between Low Bone Mineral Density and Fractures With Incident Cardiovascular Disease: A Systematic Review and Meta-Analysis
- (2017) Nicola Veronese et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts
- (2017) Sang Wan Kim et al. JOURNAL OF BONE AND MINERAL RESEARCH
- BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial
- (2017) Francis H Glorieux et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots
- (2017) Keertik Fulzele et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study
- (2017) David W Dempster et al. JOURNAL OF BONE AND MINERAL RESEARCH
- GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation
- (2017) Mehdi Amirhosseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia
- (2017) Lothar Seefried et al. JOURNAL OF CLINICAL INVESTIGATION
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- The Utility of Biomarkers in Osteoporosis Management
- (2017) Patrick Garnero Molecular Diagnosis & Therapy
- Bone diseases: Romosozumab — on track or derailed?
- (2017) Sundeep Khosla Nature Reviews Endocrinology
- Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know
- (2017) Pierre Delanaye et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Romosozumab — Promising or Practice Changing?
- (2017) Clifford J. Rosen NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
- (2017) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures
- (2017) N. C. W. Harvey et al. OSTEOPOROSIS INTERNATIONAL
- Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34)
- (2017) Jacquelin Jolette et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Sodium fluoride PET imaging as a quantitative pharmacodynamic biomarker for bone homeostasis during anti-DKK1 therapy for multiple myeloma
- (2017) Y Wang et al. Blood Cancer Journal
- Ultraviolet B Exposure Inhibits Angiotensin II–Induced Abdominal Aortic Aneurysm Formation in Mice by Expanding CD4 + Foxp3 + Regulatory T Cells
- (2017) Tomohiro Hayashi et al. Journal of the American Heart Association
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Using Osteoporosis Therapies in Combination
- (2017) Michael R. McClung Current Osteoporosis Reports
- Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
- (2017) Geert J. Behets et al. PLoS One
- Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants
- (2017) Lena Tschiderer et al. PLoS One
- Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and AtherosclerosisHighlights
- (2016) Smriti Murali Krishna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Imatinib treatment attenuates growth and inflammation of angiotensin II induced abdominal aortic aneurysm
- (2016) Emina Vorkapic et al. ATHEROSCLEROSIS
- Bisphosphonates for cardiovascular risk reduction: A systematic review and meta-analysis
- (2016) Guido Kranenburg et al. ATHEROSCLEROSIS
- Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model
- (2016) Cristal S. Yee et al. BONE
- Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice
- (2016) Carlos Tarín et al. CARDIOVASCULAR RESEARCH
- D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization
- (2016) Nicolas H. Pope et al. FASEB JOURNAL
- Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis
- (2016) Bruce E. Sands et al. INFLAMMATORY BOWEL DISEASES
- Anti-sclerostin – is there an indication?
- (2016) Sune Larsson INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- RANKL promotes osteoblastic activity in vascular smooth muscle cells by upregulating endothelial BMP-2 release
- (2016) Colin Davenport et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Inhibition of BET bromodomain attenuates angiotensin II induced abdominal aortic aneurysm in ApoE −/− mice
- (2016) Qiong Duan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Systematic review and meta-analysis for the association of bone mineral density and osteoporosis/osteopenia with vascular calcification in women
- (2016) Yiyun Zhang et al. International Journal of Rheumatic Diseases
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice
- (2016) Kyoko Kohashi et al. Journal of Atherosclerosis and Thrombosis
- A Crisis in the Treatment of Osteoporosis
- (2016) Sundeep Khosla et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Abaloparatide Is an Anabolic, but Does It Spare Resorption?
- (2016) T. John Martin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Improves the Bone Phenotype ofCrtap-/-Mice, a Model of Recessive Osteogenesis Imperfecta
- (2016) Ingo Grafe et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone
- (2016) Igor Fijalkowski et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
- (2016) Harry K Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys
- (2016) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)
- (2016) J. N. Tsai et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Calorie restriction protects against experimental abdominal aortic aneurysms in mice
- (2016) Yue Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dual Effects of Bisphosphonates on Ectopic Skin and Vascular Soft Tissue Mineralization versus Bone Microarchitecture in a Mouse Model of Generalized Arterial Calcification of Infancy
- (2016) Qiaoli Li et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The heart and vascular system in dialysis
- (2016) Christoph Wanner et al. LANCET
- Romosozumab — getting there but not quite yet
- (2016) Socrates E. Papapoulos Nature Reviews Endocrinology
- Osteocytic signalling pathways as therapeutic targets for bone fragility
- (2016) Lilian I. Plotkin et al. Nature Reviews Endocrinology
- Building Better Bones with Biologics — A New Approach to Osteoporosis?
- (2016) Clifford J. Rosen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases
- (2016) T. John Martin PHYSIOLOGICAL REVIEWS
- Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study
- (2016) Luc Chouinard et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Differentiation of Vascular Stem Cells Contributes to Ectopic Calcification of Atherosclerotic Plaque
- (2016) Aleksandra Leszczynska et al. STEM CELLS
- Vertebral Implantation of NELL-1 Enhances Bone Formation in an Osteoporotic Sheep Model
- (2016) Aaron W. James et al. TISSUE ENGINEERING PART A
- Antiosteoporotic effect of icariin in ovariectomized rats is mediated via the Wnt/β-catenin pathway
- (2016) GUANGMING CHEN et al. Experimental and Therapeutic Medicine
- Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
- (2016) Bente Langdahl et al. Therapeutic Advances in Musculoskeletal Disease
- Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administration
- (2015) Jin Hee Kwak et al. BIOMATERIALS
- Abdominal aortic calcification and risk of fracture among older women — The SOF study
- (2015) Pawel Szulc et al. BONE
- Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment
- (2015) Benjamin P. Sinder et al. BONE
- Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling
- (2015) Hongting Jin et al. BONE
- Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis
- (2015) Christian Graeff et al. BONE
- Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia
- (2015) Zahra Achiou et al. BONE
- LRP4 in neuromuscular junction and bone development and diseases
- (2015) Chengyong Shen et al. BONE
- Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats
- (2015) Yang Liu et al. CALCIFIED TISSUE INTERNATIONAL
- Stimulation of Wnt/β-Catenin Signaling to Improve Bone Development by Naringin via Interacting with AMPK and Akt
- (2015) Dawei Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Omega 3 Polyunsaturated Fatty Acids Suppress the Development of Aortic Aneurysms Through the Inhibition of Macrophage-Mediated Inflammation
- (2015) Takuma Yoshihara et al. CIRCULATION JOURNAL
- Vascular Smooth Muscle LRP6 Limits Arteriosclerotic Calcification in Diabetic LDLR−/−Mice by Restraining Noncanonical Wnt SignalsNovelty and Significance
- (2015) Su-Li Cheng et al. CIRCULATION RESEARCH
- Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification
- (2015) Lucie Hénaut et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Soybean isoflavone treatment induces osteoblast differentiation and proliferation by regulating analysis of Wnt/β-catenin pathway
- (2015) Fang Yu et al. GENE
- Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model
- (2015) Brian A. Tinsley et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Co-administration of Antiresorptive and Anabolic Agents: A Missed Opportunity
- (2015) Ego Seeman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways
- (2015) Megan M Weivoda et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Anti-Sclerostin Antibody Treatment in a Rat Model of Progressive Renal Osteodystrophy
- (2015) Sharon M Moe et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density
- (2015) Christopher P Recknor et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
- (2015) Robert R. Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Association Between Bisphosphonates Therapy and Incident Myocardial Infarction
- (2015) Bao-tao Huang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice
- (2015) Maria Borrell-Pagès et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients
- (2015) P. Evenepoel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sclerostin and DKK1: new players in renal bone and vascular disease
- (2015) Pieter Evenepoel et al. KIDNEY INTERNATIONAL
- Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
- (2015) Abdul Rashid Qureshi et al. KIDNEY INTERNATIONAL
- Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength
- (2015) W. Yao et al. OSTEOPOROSIS INTERNATIONAL
- Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption
- (2015) Lei Xiong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NELL-1 in the treatment of osteoporotic bone loss
- (2015) Aaron W. James et al. Nature Communications
- Sclerostin and CKD-MBD
- (2015) Susan C. Schiavi Current Osteoporosis Reports
- Antagonism of toll-like receptor 2 attenuates the formation and progression of abdominal aortic aneurysm
- (2015) Huimin Yan et al. Acta Pharmaceutica Sinica B
- Osteoprotegerin Deficiency Limits Angiotensin II–Induced Aortic Dilatation and Rupture in the Apolipoprotein E–Knockout Mouse
- (2014) Corey S. Moran et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesterol modulates LRP5 expression in the vessel wall
- (2014) M. Borrell-Pages et al. ATHEROSCLEROSIS
- Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats
- (2014) Marina Stolina et al. BONE
- A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events
- (2014) Swaminathan P. Iyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Sirtuin1 Activator SRT3025 Down-Regulates Sclerostin and Rescues Ovariectomy-Induced Bone Loss and Biomechanical Deterioration in Female Mice
- (2014) Hanna Artsi et al. ENDOCRINOLOGY
- Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody
- (2014) Xiaodong Li et al. ENDOCRINOLOGY
- Bone Matrix Quality After Sclerostin Antibody Treatment
- (2014) Ryan D Ross et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA-HRpQCT Study
- (2014) Joy N Tsai et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients
- (2014) Mehmet Kanbay et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Relationships Between Serum Sclerostin, Bone Mineral Density, and Vascular Calcification in Rheumatoid Arthritis
- (2014) J. Paccou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- CKD-Induced Wingless/Integration1 Inhibitors and Phosphorus Cause the CKD-Mineral and Bone Disorder
- (2014) Y. Fang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
- (2014) C. Drechsler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength
- (2014) B. P. Sinder et al. OSTEOPOROSIS INTERNATIONAL
- Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
- (2014) Ming-Kang Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical Toxicity of AZD7969
- (2014) A. P. Hall et al. TOXICOLOGIC PATHOLOGY
- Dkk1 and Msx2–Wnt7b Signaling Reciprocally Regulate the Endothelial–Mesenchymal Transition in Aortic Endothelial Cells
- (2013) Su-Li Cheng et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women
- (2013) Geeta Hampson et al. BONE
- In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma
- (2013) Samantha Pozzi et al. BONE
- Vascular Calcification: An Update on Mechanisms and Challenges in Treatment
- (2013) Meiting Wu et al. CALCIFIED TISSUE INTERNATIONAL
- Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway
- (2013) Shih-Hung Tsai et al. CARDIOVASCULAR RESEARCH
- Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
- (2013) S. Morales-Santana et al. DIABETES CARE
- The Osteocyte: An Endocrine Cell … and More
- (2013) Sarah L. Dallas et al. ENDOCRINE REVIEWS
- Single- and Multiple-Dose Randomized Studies of Blosozumab, a Monoclonal Antibody Against Sclerostin, in Healthy Postmenopausal Women
- (2013) Juliet McColm et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody
- (2013) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and Women
- (2013) Claire Durosier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Severe Abdominal Aortic Calcification in Older Men Is Negatively Associated With DKK1 Serum Levels: The STRAMBO Study
- (2013) P. Szulc et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Renal Elimination of Sclerostin Increases With Declining Kidney Function
- (2013) Daniel Cejka et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study
- (2013) Desmond Padhi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Age- and Menopause-Related Bone Loss Compromise Cortical and Trabecular Microstructure
- (2013) E. Seeman JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
- (2013) Joy N Tsai et al. LANCET
- WNT signaling in bone homeostasis and disease: from human mutations to treatments
- (2013) Roland Baron et al. NATURE MEDICINE
- Sclerostin Inhibition Reverses Skeletal Fragility in an Lrp5-Deficient Mouse Model of OPPG Syndrome
- (2013) R. Kedlaya et al. Science Translational Medicine
- Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
- (2013) Vincent M Brandenburg et al. BMC Nephrology
- Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover
- (2012) Maria P. Yavropoulou et al. BONE
- Effects of PTH on osteocyte function
- (2012) Teresita Bellido et al. BONE
- The osteocyte in CKD: New concepts regarding the role of FGF23 in mineral metabolism and systemic complications
- (2012) Katherine Wesseling-Perry et al. BONE
- Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper
- (2012) J. Goldhahn et al. CALCIFIED TISSUE INTERNATIONAL
- Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
- (2012) Hua Zhu Ke et al. ENDOCRINE REVIEWS
- Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
- (2012) Yves Sabbagh et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Van Buchem disease: Clinical, biochemical, and densitometric features of patients and disease carriers
- (2012) Antoon H van Lierop et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
- (2012) Christine Hamann et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
- (2012) Roland Baron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Plasma Dickkopf1 (DKK1) Concentrations Negatively Associate with Atherosclerotic Calcified Plaque in African-Americans with Type 2 Diabetes
- (2012) Thomas C. Register et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Arterial calcification and bone physiology: role of the bone–vascular axis
- (2012) Bithika Thompson et al. Nature Reviews Endocrinology
- Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
- (2012) J.-H. Kang et al. OSTEOPOROSIS INTERNATIONAL
- A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke
- (2012) J.-H. Kang et al. OSTEOPOROSIS INTERNATIONAL
- NELL-1 Injection Maintains Long-Bone Quantity and Quality in an Ovariectomy-Induced Osteoporotic Senile Rat Model
- (2012) Jinny Kwak et al. TISSUE ENGINEERING PART A
- Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone
- (2011) M. Marenzana et al. ARTHRITIS AND RHEUMATISM
- A new function of Nell-1 protein in repressing adipogenic differentiation
- (2011) Aaron W. James et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pharmacology of bisphosphonates
- (2011) Serge Cremers et al. BONE
- Acute Myocardial Infarction and Atherosclerosis of the Coronary Arteries in Patients Treated with Drugs Against Osteoporosis: Calcium in the Vessels and not the Bones?
- (2011) Peter Vestergaard CALCIFIED TISSUE INTERNATIONAL
- The Regulation of Valvular and Vascular Sclerosis by Osteogenic Morphogens
- (2011) Kristina I. Boström et al. CIRCULATION RESEARCH
- Alendronate and Raloxifene Use Related to Cardiovascular Diseases: Differentiation by Different Dosing Regimens of Alendronate
- (2011) Pei-Yu Lu et al. CLINICAL THERAPEUTICS
- Sirt1 Is a Regulator of Bone Mass and a Repressor ofSostEncoding for Sclerostin, a Bone Formation Inhibitor
- (2011) Einav Cohen-Kfir et al. ENDOCRINOLOGY
- Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats
- (2011) Xiaodong Li et al. ENDOCRINOLOGY
- Bone Overgrowth-associated Mutations in theLRP4Gene Impair Sclerostin Facilitator Function
- (2011) Olivier Leupin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury
- (2011) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
- (2011) Antoon H van Lierop et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Determination of Serum and Plasma Sclerostin Concentrations by Enzyme-Linked Immunoassays
- (2011) Melissa McNulty et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody
- (2011) H. Glantschnig et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys
- (2010) Sutada Lotinun et al. BONE
- The syndromic status of sclerosteosis and van Buchem disease
- (2010) P. Beighton et al. CLINICAL GENETICS
- Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice
- (2010) Gang-Qing Yao et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Genome-wide pleiotropy of osteoporosis-related phenotypes: The framingham study
- (2010) David Karasik et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
- (2010) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2+/− mice
- (2010) Xinli Zhang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women
- (2010) Sammy Elmariah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Proteomics Characterization of Extracellular Space Components in the Human Aorta
- (2010) Athanasios Didangelos et al. MOLECULAR & CELLULAR PROTEOMICS
- Delivery of Lyophilized Nell-1 in a Rat Spinal Fusion Model
- (2010) Weiming Li et al. TISSUE ENGINEERING PART A
- Nell-1 Protein Promotes Bone Formation in a Sheep Spinal Fusion Model
- (2010) Ronald K. Siu et al. TISSUE ENGINEERING PART A
- Dickkopf-1 Enhances Inflammatory Interaction Between Platelets and Endothelial Cells and Shows Increased Expression in Atherosclerosis
- (2009) Thor Ueland et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Sclerostin in Mineralized Matrices and van Buchem Disease
- (2009) R.L. van Bezooijen et al. JOURNAL OF DENTAL RESEARCH
- Generalized arterial calcification of infancy: treatment with bisphosphonates
- (2009) Kim A Ramjan et al. Nature Reviews Endocrinology
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteoprotegerin, vascular calcification and atherosclerosis
- (2008) Ann Van Campenhout et al. ATHEROSCLEROSIS
- Bisphosphonates: how do they work?
- (2008) Socrates E. Papapoulos BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- The role of Dickkopf-1 in bone development, homeostasis, and disease
- (2008) J. J. Pinzone et al. BLOOD
- Vascular Calcification
- (2008) Linda L. Demer et al. CIRCULATION
- Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity
- (2008) R. S. Pearsall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Endothelial Cell Cytoskeletal Reorganization by a Secreted Frizzled-Related Protein-1 and Frizzled 4- and Frizzled 7-Dependent Pathway
- (2007) Pascale Dufourcq et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search